MP CARDIOFLOW-B Announces New Leadership Appointments

Stock News

Yesterday

MP CARDIOFLOW-B (02160) has announced a series of executive changes effective August 26, 2026. Mr. Zhang Ruinian has stepped down from his role as Chief Executive Officer and has been appointed as President of the company.

Mr. Chen Guoming has resigned as Chairman of the Board, transitioning from Non-Executive Director to Executive Director, and has been appointed as the new Chief Executive Officer. Additionally, he has ceased to be a member of the Audit Committee and has been appointed as a member of the Nomination Committee.

Dr. Brian Chang has been appointed as Chairman of the Board and a member of the Audit Committee, while simultaneously stepping down from the Nomination Committee.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketb.com/news/1128341122"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1128341122\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1128341122?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-26 23:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1128341122","market":"nz","top_or_hot":-1,"title":"MP CARDIOFLOW-B Announces New Leadership Appointments","media":"Stock News","content":"<p><b>MP CARDIOFLOW-B</b> (02160) has announced a series of executive changes effective August 26, 2026. Mr. Zhang Ruinian has stepped down from his role as Chief Executive Officer and has been appointed as President of the company.<br><br>Mr. Chen Guoming has resigned as Chairman of the Board, transitioning from Non-Executive Director to Executive Director, and has been appointed as the new Chief Executive Officer. Additionally, he has ceased to be a member of the Audit Committee and has been appointed as a member of the Nomination Committee.<br><br>Dr. Brian Chang has been appointed as Chairman of the Board and a member of the Audit Committee, while simultaneously stepping down from the Nomination Committee.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MP CARDIOFLOW-B Announces New Leadership Appointments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMP CARDIOFLOW-B Announces New Leadership Appointments\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-08-26 23:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>MP CARDIOFLOW-B</b> (02160) has announced a series of executive changes effective August 26, 2026. Mr. Zhang Ruinian has stepped down from his role as Chief Executive Officer and has been appointed as President of the company.<br><br>Mr. Chen Guoming has resigned as Chairman of the Board, transitioning from Non-Executive Director to Executive Director, and has been appointed as the new Chief Executive Officer. Additionally, he has ceased to be a member of the Audit Committee and has been appointed as a member of the Nomination Committee.<br><br>Dr. Brian Chang has been appointed as Chairman of the Board and a member of the Audit Committee, while simultaneously stepping down from the Nomination Committee.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1583","symbol_name":"高瓴概念","start_time":0,"source_url":"","article_id":"1128341122","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1128341122","pubTimestamp":1787756533,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"MP CARDIOFLOW-B (02160) has announced a series of executive changes effective August 26, 2026. Mr. Zhang Ruinian has stepped down from his role as Chief Executive Officer and has been appointed as...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1583":"高瓴概念","BK1225":"钢铁","BK1239":"汽车零售","BK1100":"医疗保健设备","02160":"微创心通-B","BK1574":"生物医药B类股","02918":"微创心通-B"},"translate_title":"MP CARDIOFLOW-B 宣布新的领导层任命","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02160":1,"02918":1},"content_text":"MP CARDIOFLOW-B (02160) has announced a series of executive changes effective August 26, 2026. Mr. Zhang Ruinian has stepped down from his role as Chief Executive Officer and has been appointed as President of the company.Mr. Chen Guoming has resigned as Chairman of the Board, transitioning from Non-Executive Director to Executive Director, and has been appointed as the new Chief Executive Officer. Additionally, he has ceased to be a member of the Audit Committee and has been appointed as a member of the Nomination Committee.Dr. Brian Chang has been appointed as Chairman of the Board and a member of the Audit Committee, while simultaneously stepping down from the Nomination Committee.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}